Nontuberculous mycobacterial pulmonary disease
- 作者: Roytberg G.E.1,2, Gritzay A.A.2, Davydova A.S.1,2, Bulanova N.A.1,2
-
隶属关系:
- Pirogov Russian National Research Medical University
- Joint Stock Company «Medicina»
- 期: 卷 29, 编号 1 (2025): PHYSIOLOGY. EXPERIMENTAL PHYSIOLOGY
- 页面: 116-123
- 栏目: therapeutic profile diseases
- URL: https://journals.rcsi.science/2313-0245/article/view/349503
- DOI: https://doi.org/10.22363/2313-0245-2025-29-1-116-123
- EDN: https://elibrary.ru/GTYRAJ
- ID: 349503
如何引用文章
全文:
详细
The article presents a case report of nontuberculous mycobacterial pulmonary disease. Nontuberculous mycobacterial pulmonary disease is frequently underdiagnosed due to the absence of clinical signs, a nonspecific X-ray picture, as well as the difficulties of using molecular genetic diagnostic tests in primary health care setting. Some patients especially those with underlying respiratory diseases, are at increased risk of developing nontuberculous mycobacterial pulmonary disease. Identification of patients at risk is essential to allow for prompt testing and diagnosis and appropriate management to prevent disease progression.
作者简介
Grigory Roytberg
Pirogov Russian National Research Medical University; Joint Stock Company «Medicina»
Email: bulanovanatalia@outlook.com
ORCID iD: 0000-0003-0514-9114
SPIN 代码: 1032-9122
Moscow, Russian Federation
Alla Gritzay
Joint Stock Company «Medicina»
Email: bulanovanatalia@outlook.com
ORCID iD: 0009-0006-4102-6276
Moscow, Russian Federation
Alina Davydova
Pirogov Russian National Research Medical University; Joint Stock Company «Medicina»
Email: bulanovanatalia@outlook.com
ORCID iD: 0000-0002-5738-0740
SPIN 代码: 5217-8213
Moscow, Russian Federation
Natalia Bulanova
Pirogov Russian National Research Medical University; Joint Stock Company «Medicina»
编辑信件的主要联系方式.
Email: bulanovanatalia@outlook.com
ORCID iD: 0000-0001-7559-7030
SPIN 代码: 1306-8984
Moscow, Russian Federation
参考
- Izumi K, Morimoto K, Hasegawa N, Uchimura K, Kawatsu L, Ato M, Mitarai S. Epidemiology of adults and children treated for nontuberculous mycobacterial pulmonary disease in Japan. Ann Am Thorac Soc. 2019;3:341—347. doi: 10.1513/AnnalsATS.201806-366OC
- Thomson RM; NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;10:1576—83. doi: 10.3201/eid1610.091201
- Griffith DE, Aksamit TR. Managing mycobacterium avium complex lung disease with a little help from my friend. Chest. 2021;4:1372—1381. doi: 10.1016/j.chest.2020.10.031
- Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008—2015. Ann Am Thorac Soc. 2020;2:178—185. doi: 10.1513/AnnalsATS.201804-236OC
- Nontuberculous mycobacterioses of the lungs. A draft of clinical guidelines. 2023. Russian Respiratory Society. Moscow society of phthisiatricians. https://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ Access from 20.07.2024. [In Russian.]
- Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;185(5):575—583. doi: 10.1164/rccm.201107-1203OC.
- Vladimirova EB, Shmelev EI, Zaytseva AS, Kovalevskaya MN, Kasimtseva SA, Amansakhedov RB, Chernousova LN, Ergeshov AE, Shmeleva NM. Non-tuberculous mycobacteriosis of the lungs — diagnostic possibilities in the practice of the pulmonologist. Therapeutic Archive. 2019;91(11):31—36. doi: 10.26442/00403660.2019.11.000306. [In Russian.]
- Ushkov A, Azarov A, Archakova L. Disseminated lung damage with non-tuberculous mycobacteriosis (lady Windermere syndrome). Medical alliance. 2020;8(1):75—79. doi: 10.36422/23076348-2020-8-1-75-79. [In Russian.]
- Nasiri MJ, Ebrahimi G, Arefzadeh S, Zamani S, Nikpor Z, Mirsaeidi M. Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2020;3:263—273. doi: 10.1080/14787210.2020.1720650.
- Ushiki A, Tanaka S, Yamanaka M, Akahane J, Ikuyama Y, Komatsu M., Sonehara K, Ichiyama T, Wada Y, Tateishi K, Kitaguchi Y, Hanaoka M. Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease. Sci Rep. 2024;14:4438. doi: 10.1038/s41598-024-55135-0.
补充文件
